Component I ‘Enabling pre-emptive testing’ would like to inform all partners that the IT decision support infrastructure works in all three intervention-first implementation sites! This includes for example that the genotyping platforms and card printers are operational and the genotype-haplotype-phenotype translation table has been approved. Continue reading
After Granada, Liverpool, Patras and Aviano have also received ethical approval for the PREPARE study protocol. Liverpool only needs to receive approval from the Royal Liverpool R&D department (NHS). In Leiden and Ljubljana approval is awaited. In Vienna, there is a discussion whether or not the study is categorized as drug trial, but they have permission to start with the control arm. We expect to have all approvals in place at the end of January.
In the past three weeks, hospital pharmacist Jesse Swen and PhD candidate Cathelijne van der Wouden (coordinating team at LUMC) have visited all PREPARE study sites to meet the local research teams. Continue reading
Again exciting news. Cristina Fajardo (Granada, Spain) has just announced that the ethical committee of Andalucia has approved the protocol! The team in Granada is now working on the final preparations and is then ready to start. Continue reading
After the submission of the PREPARE study protocol in Spain, Italy and Austria, the other four countries, i.e. Greece, Slovenia, UK and the Netherlands, have now also submitted the protocol to their respective IRBs. Hopefully we will soon receive the first approvals so we can start recruiting patients.
After Spain, also CRO Aviano in Italy and the Medical University of Vienna in Austria have submitted the PREPARE protocol to their respective IRBs.
Exciting news! The group in Granada, Spain, is the first who has submitted the PREPARE study protocol! Hopefully more will follow soon. We will keep you posted.
The 2nd U-PGx Annual Consortium Meeting will take place on May 10-11, 2017 in Vienna, Austria. On May 12, the 2nd U-PGx Personalized Medicine Day will be organized in Vienna.
Save the dates!
The production of the video that visualizes and promotes the idea of personalized medicine and pre-emptive PGx testing is almost finished. This promotional video broadcasts Henk-Jan Guchelaar, Jesse Swen, Vita Dolzan, Matthias Schwab and Julia Stingl (voice-over), and is produced by our colleagues at BfArM. The video will be used for educational purposes of the general public at the U-PGx website and (inter)national workshops, and for communication with various stakeholders. The video will appear for the first time in Athens on September 28.
In the first week of August, the randomisation for the U-PGx implementation study took place. The randomisation results have been incorporated in the study protocol which is now almost completed. Continue reading